65 i b, drugs, pharmaceuticals,&hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79718D0566
Awardee
Awarding agency
Task orders
8

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 95% complete
IDV ceiling
$1,464,233,597.75
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

GSA issued a Federal Supply Schedule contract to Biogen U.S. Corporation under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on September 15, 2018, with a ceiling value of $1,464,233,597.75 and ultimate completion date of March 31, 2027. This is a temporary extension of the original multi-award schedule vehicle, serving as a catalog-based procurement mechanism through which federal agencies place delivery orders without conducting new competitions.

Under this schedule, Biogen supplies pharmaceutical products to the Department of Veterans Affairs through various Veterans Integrated Service Networks. Recent delivery order activity includes multiple orders for QALSODY (tofersen), a neurological disease therapy, issued by VISN 20 and VISN 21 between March 2024 and November 2024, ranging from $10,869.15 to $43,476.60 per order, with performance at Cambridge, Massachusetts. All delivery orders are firm-fixed-price with no set-aside designation.

The schedule also supports Blanket Purchase Agreements for Spinraza (used to treat spinal muscular atrophy), including a single-award BPA with a $430,578.10 ceiling awarded December 4, 2023 and completion date of October 29, 2025, and a predecessor BPA with a $572,200.00 ceiling awarded December 4, 2018 that was completed and updated for 2023 public law pricing on December 3, 2023.

Biogen competes on the open market under this schedule vehicle with no small business set-aside or socioeconomic designation applied to orders.

Task orders

IDV awards

IDV Agency Ceiling Awarded
36E79724A0003 BPA for spinraza National Acquisition Center (VA) $430,578
36E79719A0008 BPA for sprinraza National Acquisition Center (VA) $572,200

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00099 · Commercial item(s) temporary price reduction (TPR) $0
Supplemental Agreement for work within scope P00098 · Commercial item(s) - temporary price reductions (TPR) $0
Supplemental Agreement for work within scope P00097 · Commercial item(s) temporary price reduction (TPR) $0
Supplemental Agreement for work within scope P00096 · Temporary extension $0
Supplemental Agreement for work within scope P00095 · Voluntary TPR $0
Supplemental Agreement for work within scope P00092 · Life cycle change at temporary FCP $0
Supplemental Agreement for work within scope P00089 · Product addition $0
Supplemental Agreement for work within scope P00090 · Converting schedule to evergreen $0
Other Administrative Action P00091 · Revised signatory authority form $0
Supplemental Agreement for work within scope P00088 · Updating the tracking customer for one product $0
Supplemental Agreement for work within scope P00087 · Product deletion of 1X NDC MOD $0
Supplemental Agreement for work within scope P00086 · Incorporating the approved 2026 small business subcontracting plan into the contract. $0
Supplemental Agreement for work within scope P00085 · Voluntary temporary price decrease for 1 product $0
Supplemental Agreement for work within scope P00084 · Non-voluntary price decrease for 1 product $0
Supplemental Agreement for work within scope P00083 · Non-voluntary price decrease for one product $0
Supplemental Agreement for work within scope P00082 · Voluntary price decrease $0
Supplemental Agreement for work within scope P00081 · 2026 public law pricing update for 19 products $0
Supplemental Agreement for work within scope P00080 · Removal of one product from contract $0
Supplemental Agreement for work within scope P00079 · Changing the national drug code for 1 product. $0
Supplemental Agreement for work within scope P00078 · 42-2A voluntary temporary price reduction for 1 NDC $0
Supplemental Agreement for work within scope P00077 · Deletion of two 42-2A ndcs. $0
Supplemental Agreement for work within scope P00076 · Voluntary temporary price decrease for 5 ndcs. $0
Supplemental Agreement for work within scope P00074 · Approved 2025 small business subcontracting plan $0
Supplemental Agreement for work within scope P00075 · Short term contract extension $0
Add Subcontract Plan P00073 · Commercial changes (sub-contracting plan) $0
Supplemental Agreement for work within scope P00072 · Administrative change to update ordering process. $0
Supplemental Agreement for work within scope P00070 · Voluntary temporary price reductions $0
Supplemental Agreement for work within scope P00069 · 2025 public law pricing update $0
Supplemental Agreement for work within scope P00067 · Temporary short term contract extension $0
Supplemental Agreement for work within scope P00062 · Temporary price reduction $0
Supplemental Agreement for work within scope P00061 · 2024 public law pricing update $0
Supplemental Agreement for work within scope P00060 · Temporary price reduction for 1 NDC $0
Supplemental Agreement for work within scope P00058 · 42-2A product addition for 1 NDC $0
Supplemental Agreement for work within scope P00059 · Incorporate temporary price reductions for six 42-2A ndcs. $0
Supplemental Agreement for work within scope P00057 · Temporary FCP life cycle change for 1 NDC $0
Supplemental Agreement for work within scope P00056 · 2023 small business subcontracting plan $0
Supplemental Agreement for work within scope P00055 · 42-2A product addition at provisional FCP - 1 NDC $0
Supplemental Agreement for work within scope P00054 · 42-2A voluntary price decrease for 1 NDC $0
Supplemental Agreement for work within scope P00053 · Temporary contract extension $0
Other Administrative Action P00052 · Update ordering summary for spinraza $0
Supplemental Agreement for work within scope P00051 · Temporary price reduction for 1 NDC $0
Supplemental Agreement for work within scope P00050 · Permanent life cycle change for 1 NDC $0
Supplemental Agreement for work within scope P00048 · 2023 public law update $0
Supplemental Agreement for work within scope P00049 · 42-2A temporary price reduction for 6 ndcs $0
Supplemental Agreement for work within scope P00047 · 2022 small business subcontracting plan $0
Supplemental Agreement for work within scope P00046 · 42-2A temporary price reduction for 1 NDC $0
Supplemental Agreement for work within scope P00045 · Temporary life cycle change for 1 NDC $0
Supplemental Agreement for work within scope P00044 · 42-2A product addition for 1 item $0
Other Administrative Action P00043 · Administrative change to update signatory authority form $0
Supplemental Agreement for work within scope P00042 · Administrative change for sales point of contact $0
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Quick answers

Who was awarded contract 36F79718D0566?

36F79718D0566 was awarded to Biogen U.s. Corporation by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 15, 2018.

How much is contract 36F79718D0566 worth?

36F79718D0566's own ceiling is $1,464,233,598.

How many orders have been placed under contract 36F79718D0566?

8 orders have been placed under 36F79718D0566, the latest on November 13, 2024.

Who can order from contract 36F79718D0566?

36F79718D0566 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79718D0566 part of a contract vehicle?

Yes. 36F79718D0566 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79718D0566 competed?

The extent of competition for 36F79718D0566 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV